Cerulean Pharma reported $124.5M in Market Capitalization this March of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Adamis Pharmaceuticals ADMP:US 0.09B 0B
Agile Therapeutics AGRX:US $ 0B 0.06B
Arrowhead Research ARWR:US $ 4.86B 2.07B
Bayer BAYN:GR 61.51B 15.23B
Biocept BIOC:US $ 0.04B 0.02B
Brainstorm Cell Therapeutics BCLI:US $ 0.12B 0.02B
Cerulean Pharma CERU:US $ 0.17B 0.05B
Immunogen IMGN:US $ 1.05B 0.54B
Merk MRK:US $ 207.45B 13.86B
Nektar Therapeutics NKTR:US $ 2.49B 0.81B
Perrigo Ordinary Shares PRGO:US 5.17B 0.03B
Seattle Genetics SGEN:US $ 26.45B 1.82B
YTE INCY:US $ 17.58B 1.36B